Management of musculoskeletal pain in retail drug outlets within a Nigerian community: a descriptive study
Objective: This work aimed to describe attitudes and practices of both community pharmacies and patent and proprietary medicine vendor (PPMV) outlets towards over-the-counter (OTC) analgesic use for musculoskeletal pain states within Zaria, Nigeria.
Methods: The study was carried out in 2 phases from May to August 2016. Phase one was a cross-sectional survey of 40 retail drug outlets (10 community pharmacies and 30 PPMVs). A simulated patient scenario of a young adult male complaining of acute onset back pain was used to collect data on the type and quality of analgesic recommended, duration of consultation, as well as nature of information provided during the drug dispensing process. The second phase involved semi structured interviews with 7 drug vendors (4 pharmacists and 3 patent medicine vendors). The interviewees were asked questions to assess their knowledge of analgesics as well as what type of analgesic they would recommend in three hypothetical patient scenarios.
Results: A wide variety of therapeutic agents were recommended for the simulated patient. Majority of these drugs were oral analgesics and contained NSAIDS either alone or in combination. Less than half of both patent medicine outlets and pharmacies (26.7% and 40% respectively) provided the simulated patient with information on duration of therapy, and asked the patient questions about their past medical and medication history (30% and 33.3% respectively). All analgesics purchased from the pharmacies were registered with the Nigerian drug regulatory agency and had expiry dates compared to only 66.7% and 90% of those bought from patent medicine outlets. Interviewed drug vendors admitted to obtaining a large amount of their knowledge on analgesics from drug information leaflets and prior learning. They also showed some knowledge deficits when questioned on side effects of analgesics and appropriate drug selection in the hypothetical scenarios.
Conclusions: There are problems with both the OTC analgesics recommended, and the counselling provided for these medicines by drug vendors within the Zaria community. While both pharmacies and patent medicine outlets had shortcomings in several of the areas assessed by the simulated patient, the pharmacies performed better.
2. Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain. 2002;6(5):375-385.
3. Silcock J, Moffett JK, Edmonson H, Waddell G, Burton AK. Do community pharmacists have the attitudes and knowledge to support evidence based self-management of low back pain? BMC Musculoskelet Disord. 2007:8:10. doi: 10.1186/1471-2474-8-10
4. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Handout on health: back pain. at: https://www.niams.nih.gov/Health_Info/Back_Pain/default.asp#2 (accessed 20 January 2017).
5. Fuentes Albarrán K, Villa Zapata L. Analysis and quantification of self-medication patterns of customers in community pharmacies in southern Chile. Pharm World Sci. 2008;30(6):863-868. doi: 10.1007/s11096-008-9241-4
6. Nunes AP, Costa IM, Costa FA. Determinants of self-medication with NSAIDs in a Portuguese community pharmacy. Pharm Pract (Granada). 2016;14(1):648. doi: 10.18549/PharmPract.2016.01.648
7. Grézy-Chabardès C, Fournier JP, Dupouy J, Poutrain JC, Oustric S. Patients’ knowledge about analgesic-antipyretic medications purchased in community pharmacies: a descriptive study. J Pain Palliat Care Pharmacother. 2015;29(4):334-340. doi: 10.3109/15360288.2015.1082007
8. Wood DM, English E, Butt S, Ovaska H, Garnham F, Dargan PI. Patient knowledge of the paracetamol content of over-the-counter (OTC) analgesics, cough/cold remedies and prescription medications. Emerg Med J. 2010;27(11):829-833. doi: 10.1136/emj.2009.085027
9. Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA. Interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Policy Plan. 2004 May;19(3):177-182.
10. Prach LM, Treleaven E, Isiguzo C, Liu J. Care-seeking at patent and proprietary medicine vendors in Nigeria. BMC Health Serv Res. 2015;15:231. doi: 10.1186/s12913-015-0895-z
11. Peter O, Joshua E. Pattern, knowledge and other contextual correlates of use of pain-killers among students of Niger Delta University. IOSR J Pharm Biol Sci. 2016;11(2):28-36.
12. Awofisayo OS, Awofisayo OA, Iferi II, Akpan OE. The pattern of sale and use of non-steroidal anti-inflammatory drugs in rural and urban centres in Nigeria. Trop J Pharm Res. 2008;7(3):1013-1018.
13. Agaba EI, Agaba PA, Wigwe CM. Use and abuse of analgesics in Nigeria: a community survey. Niger J Med. 2004 Oct-Dec;13(4):379-382.
14. Okpalugo JI, Inyang US, Ibrahim K, Ukwe CV, Aguwa NC. Misuse of some OTC analgesics in Abuja, Nigeria. Int J Nat Appl Sci. 2010;6(1):125-130.
15. Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. Available at; http://www.fda.gov/Drugs/DrugSafety/ucm451800.htm (accessed on 10 October 2016).
16. Oguoma VM, Nwose EU, Skinner TC, Digban KA, Onyia IC, Richards RS. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health. 2015;15:397. doi: 10.1186/s12889-015-1709-2
17. Sani MU, Wahab KW, Yusuf BO, Gbadamosi M, Johnson OV, Gbadamosi A. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study. BMC Res Notes. 2010;3:11. doi: 10.1186/1756-0500-3-11
18. Wachukwu CM, Emem-Chioma PC, Wokoma FS, Oko-Jaja RI. Prevalence of risk factors for chronic kidney disease among adults in a university community in southern Nigeria. Pan Afr Med J. 2015;21:120. doi: 10.11604/pamj.2015.21.120.7079
19. Ohieku JD, Jasini TS. Non-steroidal anti-inflammatory drugs misuse among newly diagnosed and resurged peptic ulcer patients in Maiduguri-City, Nigeria. J Adv Med Pharm Sci. 2015;4(3):1-10. doi: 10.9734/JAMPS/2015/19213
20. Olokoba AB, Olokoba LB, Jimoh AA. Upper gastrointestinal tract bleeding in Ilorin, Nigeria - A report of 30 cases. Niger J Clin Pract. 2009 Sep;12(3):240-244.
21. Pharmacists Council of Nigeria. List of Licensed Pharmacists and Licensed Pharmaceutical Premises as at 31st December 2015. PCN Nigeria; 2016.
22. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. 68th ed. UK: BMJ Publishing Group. 2014.
23. Manolakis PG, Skelton JB. Pharmacists' contributions to primary care in the united states collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. Am J Pharm Educ. 2010;74(10):S7.
24. Watson MC, Cleland JA, Bond CM. Simulated patient visits with immediate feedback to improve the supply of over-the-counter medicines: a feasibility study. Fam Pract. 2009;26(6):532-542. doi: 10.1093/fampra/cmp061
25. Abdel Shaheed C, McFarlane B, Maher CG, Williams KA, Bergin J, Matthews A, McLachlan AJ. Investigating the primary care management of low back pain: a simulated patient study. J Pain. 2016;17(1):27-35. doi: 10.1016/j.jpain.2015.09.010
26. Mibielli MA, Geller M, Cohen JC, Goldberg SG, Cohen MT, Nunes CP, Oliveira LB, da Fonseca AS. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009;25(11):2589-2599. doi: 10.3111/13696990903246911
27. Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;(6):CD007402. doi: 10.1002/14651858.CD007402.pub3
28. Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281. doi: 10.1002/14651858.CD009281.pub3
29. Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010;110(4):1170-1179. doi: 10.1213/ANE.0b013e3181cf9281
30. Molloy P, Chambers R, Cork T. How well are national guidelines relating to the general sales of aspirin and paracetamol, adhered to by retail stores: a mystery shopper study. BMJ Open. 2016;6(1):e010081. doi: 10.1136/bmjopen-2015-010081
31. Okeke TA, Uzochukwu BS, Okafor HU. An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community. Malar J. 2006;5:97. doi: 10.1186/1475-2875-5-97
32. Uzochukwu BS, Onwujekwe OE, Okwuosa C, Ibe OP. Patent medicine dealers and irrational use of medicines in children: the economic cost and implications for reducing childhood mortality in Southeast Nigeria. PLoS One. 2014;9(3):e91667. doi: 10.1371/journal.pone.0091667
33. Durrance SA. Older Adults and NSAIDS: Avoiding Adverse Reactions. Geriatr Nurs. 2003;24(6):348-352